What to do after avelumab therapy failure in metastatic Merkel cell carcinoma? Chemotherapy as a bridging strategy in cases of significant tumor progression prior to off-label immunotherapy with ipilimumab and nivolumab.

Yervoy (ipilimumab) - BMS

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

Bavencio (avelumab) - EMD Serono

Jan Hendrik Maiwald; Magdalena-Sophie Greiner; Matthias Goebeler; Valerie Glutsch; Ugur Uslu; Anja Gesierich; Mareike Kotzerke

Sep 7, 2026